Sanofi Pasteur

189 articles about Sanofi Pasteur

• FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection

  9/13/2010

• FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra(R) Vaccine to Infants and Toddlers

  8/26/2010

• Sanofi Pasteur Begins Shipping Influenza Vaccine in U.S. for 2010-2011 Season

  7/30/2010

• Watchdog Group is Urging a Federal Investigation of Vaccine Pricing Policies of Drugmakers Merck & Co., Inc. and Sanofi Pasteur

  7/8/2010

• Crucell N.V. Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines

  7/8/2010

• Dengue Re-emerges in U.S., Spurring Race for Vaccine Potentially Worth $1 Billion; Sanofi Pasteur Leads the Charge, Hoping to be in Phase 3 Trials By End of Year

  6/29/2010

• Vivalis Partners With Sanofi Pasteur For The Discovery Of Human Monoclonal Antibodies Against Infectious Diseases

  6/8/2010

• .decimal, Inc. Partners with Sanofi Pasteur on Novel Prevention and Treatment for Pseudomonas aeruginosa

  1/11/2010

• US Clears High-Dose Sanofi Pasteur (JOBS) Flu Vaccine for Elderly

  12/28/2009

• Sanofi Pasteur (JOBS) Purchases Rights to Syntiron LLC's MRSA Vaccine; Sanofi Will Pay Syntiron Upfront Fee, Research Capital, and Several Milestone Payments That Could Reach $149 Million

  12/16/2009

• PHT Corporation's Market Leading LogPad(R) and StudyWorks(TM) ePRO Solutions Used in Sanofi Pasteur's Phase II Study of New Clostridium Difficile Vaccine

  12/16/2009

• Sanofi Pasteur (JOBS) Plans Layoffs At Swiftwater, Plans to Reduce Workforce by an Unspecified Number Over a Two-year Period

  12/14/2009

• Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting

  11/2/2009

• Vical Incorporated's Vaxfectin(R) Adjuvant Drives 200-Fold Increase in Antibody Responses With Sanofi Pasteur Fluzone(R) Seasonal Influenza Vaccine

  10/26/2009

• Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants and Children

  10/14/2009

• Sanofi Pasteur Announces Results of U.S. Clinical Trials in Adults Following One Dose of Influenza A (H1N1) Vaccine

  10/1/2009

• Sanofi Pasteur And VaxGen, Inc. AIDS Vaccine Works, But Back To The Drawing Board

  9/29/2009

• U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine

  9/16/2009

• Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

  8/7/2009

• Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza

  7/28/2009